Research & Innovation in Anesthesia

Register      Login

VOLUME 4 , ISSUE 1 ( January-June, 2019 ) > List of Articles


Comparative Evaluation of Efficacy and Safety of Intramuscular Butorphanol vs Epidural Butorphanol as Postoperative Analgesia in Patients Undergoing Lower Abdominal and Lower Limb Surgeries: A Randomized-controlled Study

Chaula Doshi, Varsha H Vyas, Bobby Kurian, Surekha S Patil, Deepakkumar G Langade

Keywords : Analgesia, Butorphanol, Epidural, Intramuscular, Postoperative

Citation Information : Doshi C, Vyas VH, Kurian B, Patil SS, Langade DG. Comparative Evaluation of Efficacy and Safety of Intramuscular Butorphanol vs Epidural Butorphanol as Postoperative Analgesia in Patients Undergoing Lower Abdominal and Lower Limb Surgeries: A Randomized-controlled Study. Res Inno Anesth 2019; 4 (1):1-6.

DOI: 10.5005/jp-journals-10049-0065

License: CC BY-NC 4.0

Published Online: 01-12-2019

Copyright Statement:  Copyright © 2019; The Author(s).


Context: Intramuscular (IM) butorphanol can be a convenient postoperative analgesia compared to epidural (EP) route. Aims: Compare the efficacy and safety of IM vs EP butorphanol (1 mg/2 mg) as postoperative analgesia. Settings and design: A randomized-controlled study. Materials and methods: This study was conducted on 120 adult patients of either sex in the age group of 20–60 years, undergoing lower abdominal or lower limb surgeries (American Society of Anesthesiologists [ASA] class-I/II). Patients were randomized to butorphanol intramuscularly (IM group) or EP injection (EP group). Each group had two equal subgroups where patients received either 1 mg or 2 mg by the respective route. The primary outcomes were onset of analgesia, peak time of analgesia, and duration of analgesia. Pain was assessed on a 0–10 visual analog scale (VAS), and vital parameters were assessed at baseline and after 10, 20, 30, 60, 90, 120, and 180 minutes. Clinical safety was assessed by the adverse events. Results: The duration of analgesia provided by both the routes was comparable (293.0 minutes IM and 270.25 minutes EP). However, duration of analgesia was longer (p, 0.043) with 2 mg compared to 1 mg. Similarly, the onset of analgesia, pain scores, and peak time of analgesia were similar (p > 0.05) in the two groups. No differences in the hemodynamic parameters and respiratory rate were observed in the two groups. Higher incidence of all the side effects (sedation, somnolence, pruritus) was observed with IM administration. All side effects were clinically insignificant. Conclusion: Intramuscular butorphanol is as effective as an EP for the management of immediate postoperative pain. Keymessages: Intramuscular analgesics could be more convenient and safer compared to EP administration. Butorphanol administered by the IM route is as effective and safe compared to EP administration.

  1. Bond MR, Bonica JJ, Boyd DB, et al. Classification of chronic pain. Pain 1979;6:249–252.
  2. Revar B, Patel V, Patel B, et al. A comparison of epidural butorphanol tartrate and tramadol hydrochloride for postoperative analgesia using CSEA technique. Int J Res Med 2015;4(1):1–6.
  3. Tanaka E, North RA. Opioid actions on rat anterior cingulate cortex neurons in vitro. J Neurosci 1994;14(3):1106–1113. DOI: 10.1523/JNEUROSCI.14-03-01106.1994.
  4. Kaur J, Bajwa SJS. Comparison of epidural butorphanol and fentanyl as adjuvants in the lower abdominal surgery: A randomized clinical study. Saudi J Anaesth 2014;8(2):167–171. DOI: 10.4103/1658-354X.130687.
  5. Bromage PR, Camporesi EM, Durant PA, et al. Nonrespiratory side effects of epidural morphine. Anesth Analg 1982;61(6):490–495. DOI: 10.1213/00000539-198206000-00002.
  6. Sultan P, Gutierrez MC, Carvalho B. Neuraxial morphine and respiratory depression. Drugs 2011;71(14):1807–1819. DOI: 10.2165/11596250-000000000-00000.
  7. Rosow CE. Butorphanol in perspective. Acute Care 1988; 12(Suppl 1):2–7.
  8. Von Korff M, Jensen MP, Karoly P. Assessing global pain severity by self-report in clinical and health services research. Spine (Phila Pa 1976) 2000;25(24):3140–3151.
  9. Massad I, Mahafza T, Abu-Halawah S, et al. Postoperative pain is undertreated: results from a local survey at Jordan University Hospital. East Mediterr Heal J 2013;19(5):485–489. DOI: 10.26719/2013.19.5.485.
  10. Buggy DJ, Smith G. Epidural anaesthesia and analgesia: better outcome after major surgery? Growing evidence suggests so. BMJ 1999;319(7209):530–531. DOI: 10.1136/bmj.319.7209.530.
  11. Abboud TK, Afrasiabi A, Zhu J, et al. Epidural morphine or butorphanol augments bupivacaine analgesia during labor. Reg Anesth 1989;14(3):115–120.
  12. Abboud TK, Zhu J, Afrasiabi A, et al. Epidural butorphanol augments lidocaine sensory anesthesia during labor. Reg Anesth 1991;16(5): 265–267.
  13. Mittapally S, Aerram S. Efficacy of bupivacaine and fentanyl v/s bupivacaine and butorphanol in postoperative pain relief. Sch J Appl Med Sci 2016;4:3954–3956. DOI: 10.21276/sjams.2016.4.11.19.
  14. Praveen PVVSB, Chandra V, Konda R, et al. A prospective, randomized, double blind, comparative study of intramuscular nalbuphine hydrochloride, butorphanol tartrate and pentazocine lactate for post-operative. Int J Basic Clin Pharmacol 2016;5(6):2326–2331. DOI: 10.18203/2319-2003.ijbcp20164049.
  15. Singha D, Singh J, Bhandari S. A comparative analysis of epidural butorphanol and fentanyl for post-operative analgesia in lower abdominal surgeries. Int J Med Res Prof Orig 2016;2(2):25–32.
  16. Fatima N, Singh N, Singh LK, et al. Comparative study of the effect of dexmedetomidine and butorphanol as epidural adjuvants in abdominal hysterectomy under intrathecal levobupivacaine anesthesia. J Med Soc 2016;30(3):166. DOI: 10.4103/0972-4958.191183.
  17. Kar P. A comparative study between epidural butorphanol with bupivacaine and bupivacaine alone for intra-operative and post-operative analgesia in lower limb orthopaedic surgeries. Int J Res Med Sci 2016;4(10):4251–4255. DOI: 10.18203/2320-6012.ijrms20163101.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.